In a press release, the company said that the United States Food and Drug Administration (USFDA) has successfully concluded inspection at Unichem Laboratories’ newly commissioned Active Pharmaceutical Ingredients (APIs) facility at Kolhapur in Maharashtra without any FDA form 483 being issued.

The stock has given a bounce from the edge of the rising trendline support and it is coinciding with the 100-week exponential moving average.

The stock of Avenue Supermarts Limited has given ascending triangle breakout on a weekly time frame.

The stock of Tata Consultancy Services Limited has formed the Three Black Crows candlestick pattern on weekly time frame.

On Friday, shares of Lupin closed at Rs. 756 per share, higher by 2 per cent on BSE. The stock had opened at Rs. 742.00 compared to its previous close of Rs. 741.35.

Nifty Bank index, on Friday recorded its biggest single-day gain ever as it surged by 8.31 per cent or 2223.9 points to a level of 28,981.

The positive sentiments are likely to continue and can trigger further buying in the market. The coming week will also see some earnings estimates for H2FY20E and FY21E, which can be higher than any other estimates. The positive sentiments at domestic front, though, will need some support from global markets.

After last few sessions of weakness, the Indian rupee has strengthened against the greenback (US dollar) on Friday.

USFDA has successfully completed an inspection at Anuh Pharma’s facility. Reacting to this news, the shares of the company climbed nearly 14 per cent intraday on Friday.

Strides Pharma Science’s board has approved an additional investment up to a maximum of US$ 40 million over a period of 24 months for a controlling stake in Stelis Biopharma (Stelis). Reacting to this development, shares of the company clocked an intraday gain of over 3 per cent on Friday.